Our Partners
Regenerative Medicine
asap
Australian made and owned, asap skin products is the number 1 cosmeceutical skin care brand in Australia. For over two decades, asap has provided the highest quality of simple and effective cosmeceutical skincare for all skin types. The scientifically formulated range offers concise, uncomplicated skincare and is exclusive to medical and skincare professionals.
Aesthetic Management Partners
Aesthetic Management Partners is a leading manufacturer of transformative aesthetic treatment solutions. The company’s portfolio includes plant based patented technology for skin and hair revitalization and complemented by a portfolio of aesthetic energy-based devices. Aesthetic Management Partners directly distributes its products in the US and Canada, and through international distributors in over 60 countries.
Estar Medical
Estar Medical is globally recognized as the leading provider of a patented platform method to produce Autologous Platelet Rich Plasma (PRP) and other related Cell Therapy technologies for human use. This cutting-edge platform technology is distributed under the registered trademarks of Tropocells® and Cellenis®, processes the patient’s own blood for the purpose of using the platelets, cells and essential proteins for indications in various medical disciplines such as dermatology, aesthetics, orthopedics, sports medicine, wound care, pain management, dental, ophthalmology, veterinary and more.
STD Pharmaceuticals
STD Pharmaceutical Products Ltd is a family run business formed in 1967 to supply a novel sclerosant to surgeons for the non-surgical treatment of varicose veins. Fibrovein is a liquid injection which, when injected into varicose veins can close them without the need for surgery. The treatment of varicose veins with Fibrovein offers the patient a painless walk in, walk out procedure without anaesthesia or surgery; the veins are simply injected.
AngioDynamics
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.